How To Invest In Genmab A/S Stock - GMAB Share Price Today & News | Stash
Invest in Genmab A/S on Stash
Genmab A/S is a Denmark-based international biotechnology company. It specializes in the creation and development of antibody therapeutics for the treatment of cancer, with a focus on solid tumors and hematological cancer.
To buy fractional shares of Genmab A/S stock, you'll need to sign up for Stash and open a personal portfolio.
Stash allows you to purchase smaller pieces of investments, called fractional shares, rather than having to pay the full price for a whole share.
Genmab A/S
$28.72
-3.56%
(1W)
Jul ’26Jul ’26$29$30$30
GMAB Performance Breakdown
Share Price
The last publicly stated price for one share of an investment, updated every approximately 20 minutes during market hours (usually business days between 9:30 a.m. and 4:00 p.m. ET).
$28.72
Today's change
This is how much an investment's price has changed over the last day of active trading. For example, if an investment's price was $10 yesterday, and today it rose to $11, you'd see a 1 day change of 10%.
-0.9%
Year to date change (YTD)
This is the performance of the investments since the start of the year, updated approximately every 20 minutes during market hours.
-9.74%
Dividend yield
Some investments pay you profits or interest as you hold them. These payments are called dividends, and this value represents the dollar value as a percentage of the investment's share price.
0.0
Last dividend paid
The dollar value per share that was paid out to shareholders.
N/A
Last dividend pay date
The date shareholders were paid out for the last dividend issued.
N/A
About GMAB
Genmab A/S has two approved antibodies: DARZALEX (daratumumab) and Arzerra (ofatumumab). DARZALEX is approved in combination with other standard therapies in frontline multiple myeloma, relapsed/refractory multiple myeloma and as a monotherapy for heavily pretreated or double-refractory multiple myeloma. It is marketed in the United States (U.S.), Europe and Japan. Arzerra is approved in certain territories for various chronic lymphocytic leukemia (CLL) indications and is marketed in the U.S. and Japan. The Company also develops a broad clinical and pre-clinical product pipeline, both own and partnered, and owns four proprietary antibody technologies: DuoBody bispecific platform, HexaBody platform, DuoHexaBody platform & HexElect platform.
How to buy Genmab A/S stock on Stash
Enter the amount you'd like to invest in Genmab A/S stock, then proceed to checkout.
Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.
Genmab A/S’s share price is determined by its bid-ask spread, which is the difference between the price that buyers are willing to pay and the price that sellers are willing to accept. Genmab A/S’s price can fluctuate throughout the course of each trading day.
Set up your investment account in just a few minutes.
Stash offers one subscription plan: The Stash Plan.
Once you’ve finished your account, your Genmab A/S shares will be added to your new portfolio.
Once your market order of Genmab A/S stock is complete, you'll officially be a shareholder of Genmab A/S!
Disclaimer
Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.
Ticker: GMAB
Fractional shares
Thousands of stocks and ETFs. No investing minimums.
Unlimited trades
Plus no add-on trading commission fees.†
Diversification analysis
Custom investment recommendations can help you diversify.
Automatic investing
Dividend reinvestment, recurring investments, and more.
The Stock-Back® Card
We’ll give you matching stock in companies you shop at.
Learn how to invest
Get professional advice and education at every step.